UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of biological chemistry, ISSN 0021-9258, 11/2012, Volume 287, Issue 46, pp. 38922 - 38935
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Neuronal Ceroid-Lipofuscinoses - drug therapy | Up-Regulation | Retinoid X Receptor alpha - metabolism | Serine Proteases - biosynthesis | Humans | Neuronal Ceroid-Lipofuscinoses - metabolism | Gemfibrozil - pharmacology | Hypolipidemic Agents - pharmacology | Brain - drug effects | Brain - metabolism | Fenofibrate - pharmacology | Animals | Lysosomes - metabolism | Gene Expression Regulation, Developmental | Mice | Neurons - metabolism | PPAR alpha - metabolism | Aminopeptidases - biosynthesis | Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - biosynthesis | Astrocytes - metabolism | Index Medicus | Gene Regulation | Lysosomes | Enzymology | Peroxisome Proliferator-activated Receptor (PPAR) | Astrocytes | Neurons
Journal Article
Journal of the science of food and agriculture, ISSN 0022-5142, 12/2019, Volume 99, Issue 15, pp. 6954 - 6961
quercetin | metabolic health | rat | liver | high‐fructose, high‐cholesterol diet | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Applied | Food Science & Technology | Agriculture, Multidisciplinary | Agriculture | Science & Technology | Fructose - adverse effects | Weaning | Cholesterol - blood | Cholesterol, Dietary - metabolism | Humans | Liver - metabolism | Non-alcoholic Fatty Liver Disease - etiology | Rats | Male | Non-alcoholic Fatty Liver Disease - metabolism | Rats, Sprague-Dawley | Fructose - metabolism | Non-alcoholic Fatty Liver Disease - drug therapy | Animals | Liver - drug effects | Triglycerides - blood | Quercetin - administration & dosage | Female | Cholesterol, Dietary - adverse effects | High cholesterol diet | Liver | Transaminase | Lipids | Statistical methods | Blood | Fatty liver | Rodents | Creatinine | Alanine | Liver diseases | Statistical analysis | Drinking behavior | Triglycerides | Cholesterol | Fructose | Steatosis | Fenofibrate | Urea | Organic chemistry | Diet | Quercetin | Alanine transaminase | Metabolic disorders | Index Medicus
Journal Article
Oncology, ISSN 0030-2414, 05/2012, Volume 82, Issue 5, pp. 249 - 260
Clinical Study | Tumor angiogenesis | Solid tumor | Children | Metronomic chemotherapy | Relapsed pediatric solid tumor | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Administration, Metronomic | Humans | Child, Preschool | Infant | Isotretinoin - administration & dosage | Male | Feasibility Studies | Young Adult | Angiogenesis Inhibitors - administration & dosage | Dacarbazine - analogs & derivatives | Adult | Female | Registries | Vitamin D - administration & dosage | Child | Dacarbazine - administration & dosage | Europe | Fenofibrate - administration & dosage | Etoposide - administration & dosage | Celecoxib | Neoplasms - drug therapy | Pyrazoles - administration & dosage | Adolescent | Sulfonamides - administration & dosage | Chemotherapy | Children & youth | Cancer | Index Medicus
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 11/2015, Volume 495, Issue 1, pp. 9 - 18
Absorption mechanism | Nanoemulsions | Insoluble drug | Pharmacokinetics | Globular protein | Solidification | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Nanoparticles - chemistry | Soybean Proteins - pharmacokinetics | Emulsions - adverse effects | Humans | Bile Acids and Salts - chemistry | Drug Carriers - administration & dosage | Biological Availability | Fenofibrate - chemistry | Soybean Proteins - chemistry | Drug Carriers - chemistry | Intestinal Absorption | Tissue Distribution | Emulsions - administration & dosage | Bile Acids and Salts - administration & dosage | Protein Denaturation | Water - chemistry | Bile Acids and Salts - pharmacokinetics | Caco-2 Cells | Cell Survival - drug effects | Soybean Proteins - administration & dosage | Administration, Oral | Emulsions - chemistry | Nanoparticles - ultrastructure | Solubility | Fenofibrate - administration & dosage | Rats | Chemistry, Pharmaceutical | Fenofibrate - blood | Particle Size | Fenofibrate - pharmacokinetics | Animals | Suspensions - pharmacokinetics | Drug Carriers - pharmacokinetics | Nanoparticles - administration & dosage | Emulsions - pharmacokinetics | Drugs | Drug delivery systems | Analysis | Gastrointestinal system | Vehicles | Index Medicus
Journal Article
Journal of pharmaceutical sciences, ISSN 0022-3549, 10/2009, Volume 98, Issue 10, pp. 3582 - 3595
SEDDS | lipid formulation classification system | oral drug delivery | SMEDDS | self-emulsifying systems | self-emulsifying drug delivery systems | drug precipitation | self‐emulsifying systems | self‐emulsifying drug delivery systems | Drug precipitation | Lipid formulation classification system | Self-emulsifying systems | Oral drug delivery | Selfemulsifying drug delivery systems | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Chemistry, Medicinal | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Water | Solvents | Excipients | Emulsions | Solubility | Fenofibrate - administration & dosage | Electric Conductivity | Chromatography, High Pressure Liquid | Fenofibrate - chemistry | Chemistry, Pharmaceutical | Lipids - chemistry | Solutions | Hypolipidemic Agents - administration & dosage | Pharmaceutical Preparations - chemistry | Hypolipidemic Agents - chemistry | Index Medicus
Journal Article
6.
Full Text
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics
Clinical pharmacology and therapeutics, ISSN 0009-9236, 05/2016, Volume 99, Issue 5, pp. 538 - 547
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypoglycemia - epidemiology | Glipizide - administration & dosage | Humans | Middle Aged | Glipizide - adverse effects | Male | Fenofibrate - adverse effects | Incidence | Drug Interactions | Hypoglycemic Agents - administration & dosage | Female | Retrospective Studies | Sulfonylurea Compounds - administration & dosage | Glyburide - administration & dosage | Hypoglycemia - chemically induced | Glyburide - adverse effects | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Fenofibrate - administration & dosage | Sulfonylurea Compounds - adverse effects | Algorithms | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hypolipidemic Agents - administration & dosage | Aged | Hypoglycemic Agents - adverse effects | Cohort Studies | Care and treatment | Dosage and administration | Management | Hypoglycemia | Hypoglycemic sulfonylureas | Sulfonylurea compounds | Risk factors | Public health | Index Medicus | Abridged Index Medicus | drug interactions | fibric acids | sulfonylurea compounds | hypoglycemia | cohort studies | hydroxymethylglutaryl-CoA reductase inhibitors | Medicaid | pharmacoepidemiology | propensity score
Journal Article
Pediatric blood & cancer, ISSN 1545-5009, 04/2014, Volume 61, Issue 4, pp. 636 - 642
drug resistance | pediatric oncology | phase II clinical trials | angiogenesis | Pediatric oncology | Angiogenesis | Drug resistance | Phase II clinical trials | Pediatrics | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Cyclophosphamide - administration & dosage | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Neoplasm Recurrence, Local - pathology | Young Adult | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Child | Fenofibrate - administration & dosage | Etoposide - administration & dosage | Survival Rate | Celecoxib | Thalidomide - administration & dosage | Neoplasms - drug therapy | Pyrazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Adolescent | Neoplasm Staging | Neoplasms - pathology | Sulfonamides - administration & dosage | Antimitotic agents | Chemotherapy | Relapse | Gliomas | Analysis | Leukemia | Clinical trials | Product development | Antineoplastic agents | Diseases | Cancer | Drug dosages | Cancer therapies | Tumors | Index Medicus | s
Journal Article
Neuropharmacology, ISSN 0028-3908, 04/2017, Volume 116, pp. 364 - 370
Self-administration | Addiction | Ethanol | Drug seeking | Progressive ratio | Rats | Alcohol | Ethanol reinforcement | Peroxisome proliferator-activated receptors | PPARα | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Rats, Wistar | Conditioning, Operant - physiology | Ethanol - administration & dosage | Dose-Response Relationship, Drug | Reinforcement Schedule | Fenofibrate - pharmacology | Self Administration | Animals | Alcohol Deterrents - pharmacology | Conditioning, Operant - drug effects | Alcoholism - metabolism | Central Nervous System Depressants - administration & dosage | PPAR alpha - agonists | Alcoholism - drug therapy | Dietary Sucrose | PPAR alpha - metabolism | Hypercholesterolemia | Drinking of alcoholic beverages | Index Medicus
Journal Article
9.
Full Text
Safety assessment of niacin in the US Food and Drug Administration's mini‐sentinel system
Pharmacoepidemiology and drug safety, ISSN 1053-8569, 01/2018, Volume 27, Issue 1, pp. 30 - 37
niacin | sentinel | bleeding | safety | pharmacoepidemiology | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | United States - epidemiology | Hyperlipidemias - blood | United States Food and Drug Administration - statistics & numerical data | Follow-Up Studies | Humans | Middle Aged | Male | Gastrointestinal Hemorrhage - epidemiology | Delayed-Action Preparations - administration & dosage | Fenofibrate - adverse effects | Incidence | Niacin - administration & dosage | Young Adult | Aged, 80 and over | Niacin - adverse effects | Adult | Female | Adverse Drug Reaction Reporting Systems - statistics & numerical data | Hypolipidemic Agents - adverse effects | Hyperlipidemias - drug therapy | Fenofibrate - administration & dosage | Gastrointestinal Hemorrhage - chemically induced | Delayed-Action Preparations - adverse effects | Intracranial Hemorrhages - chemically induced | Hypolipidemic Agents - administration & dosage | Cholesterol, HDL - blood | Intracranial Hemorrhages - epidemiology | Aged | Niacin | Analysis | Safety and security measures | Sensitivity analysis | Initiators | Sentinel system | Data processing | Hazards | Hemorrhage | Bleeding | Confidence intervals | Fenofibrate | Statistical models | Vitamin B | Lipoproteins (high density) | Index Medicus
Journal Article